电邮这篇文章 The role of influenza vaccination in the prevention of pulmonary and cardiovascular diseases
- 作者: Vasin A.V.1,2
-
隶属关系:
- Peter the Great Saint Petersburg Polytechnic University
- Smorodintsev Research Institute of Influenza
- 期: 卷 40, 编号 3 (2021)
- 页面: 63-67
- 栏目: Reviews
- URL: https://journals.rcsi.science/RMMArep/article/view/76445
- DOI: https://doi.org/10.17816/rmmar76445
- ID: 76445
如何引用文章
全文:
详细
Influenza is an acute respiratory disease that causes annual epidemics and periodic pandemics with high mortality. It is characterized by the development of severe complications, the main of which are pulmonary and cardiovascular ones. The only effective method of preventing influenza, and therefore the influenza-associated complications, is vaccination, which is carried out annually on the basis of World Health Organization influenza vaccines composition recommendations. This article provides the review of the research data confirming the effective role of influenza vaccination in the prevention of pulmonary and cardiovascular pathologies (bibliography: 12 refs).
作者简介
Andrey Vasin
Peter the Great Saint Petersburg Polytechnic University; Smorodintsev Research Institute of Influenza
编辑信件的主要联系方式.
Email: vasin_av@spbstu.ru
ORCID iD: 0000-0002-1391-7139
SPIN 代码: 2014-8298
D.Sc. (Biology), Associate Professor
俄罗斯联邦, 29, Politekhnicheskaya str., Saint Petersburg, 194064参考
- Kiselev OI, Tsybalova LM, Pokrovsky VI, ed. Influenza: epidemiology, clinical presentation, prevention. Influenza – the view of the virologist and the attending physician. Moscow: LLC Medical Information Agency Publisher; 2012. 496 p. (In Russ.)
- Danilenko DM, Sominina AA, Komissarov AB, et al. The effectiveness of influenza vaccination in reducing the frequency of hospitalizations, assessed at different stages of the epidemic cycle. Epidemiology and Vaccinoprophylaxis. 2019;18(5):63–69. (In Russ.)
- Characteristics of the influenza epidemic of the 2019–2020 season. In Russian federation. Report of the WHO National Influenza Centers in the Russian Federation. St. Petersburg, 2020. (In Russ.)
- Daoud A, Laktineh A. Macrander C. Mushtaq A. Soubani AO. Pulmonary complications of influenza infection: a targeted narrative review. Postgraduate Medicine. 2019;131(5):299–308.
- Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature. Ann Intern Med. 1995;123(7):518–527.
- Nichol KL., Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130(5): 397–403. doi: 10.7326/0003-4819-130-5-199903020-00003
- Puig-Barberà J, Márquez-Calderón S, Masoliver-Fores A, et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health. 1997;51(5):526–530. doi: 10.1136/jech.51.5.526
- Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine. 1999;17 Suppl 1:91–93. doi: 10.1016/s0264-410x(99)00114-0
- MacIntyre CR., Mahimbo A, Moa AM., Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102(24):1953–1956.
- Caldeira D, Ferreira JJ, Costa J. Influenza vaccination and prevention of cardiovascular disease mortality. Lancet. 2018;391(10119):426–427.
- Sen A, Bakken IJ, Govatsmark RES, et al. Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study. BMC Cardiovascular Disorders. 2021;21:31.
- Zangiabadian M, Nejadghaderi SA, Mirsaeidi M, et al. Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis. Scientific Reports. 2020;10(1):20656.
补充文件
